National Brain Tumor Society
Meets Standards
Standards For Charity Accountability
Governance
-
Board Oversight
-
Board Size
-
Board Meetings
-
Board Compensation
-
Conflict of Interest
Measuring Effectiveness
-
Effectiveness Policy
-
Effectiveness Report
Finances
-
Program Expenses
-
Fundraising Expenses
-
Accumulating Funds
-
Audit Report
-
Detailed Expense Breakdown
-
Accurate Expense Reporting
-
Budget Plan
Fundraising & Info
-
Truthful Materials
-
Annual Report
-
Website Disclosures
-
Donor Privacy
-
Cause Marketing Disclosures
-
Complaints
National Brain Tumor Society meets the 20 Standards for Charity Accountability.
Stated Purpose:
"to invest, mobilize, and unite our community to discover a cure, deliver effective treatments, and advocate for patients and care partners."
Year, State Incorporated:
1989, MA
National Brain Tumor Society (NBTS) reports that it is committed to finding better treatments, and ultimately a cure, for people living with a brain tumor. The organization funds medical research and patient care, advocates on behalf of the brain tumor community, and informs patients and their caregivers about treatment and health care. NBTS states that it is able to advance its mission through funding medical research and patient care, and by informing patients and their caregivers about treatment and health care.
For the year ended December 31, 2023, National Brain Tumor Society's program expenses were:
Program services: $10,320,599
Total Program Expenses: $10,320,599
Chief Executive
David F. Arons, JD, President and Chief Executive Officer
Compensation*
$311,217
Chair of the Board
Edjah Nduom, MD
Chair's Profession / Business Affiliation
Doctor
Board Size
15
Paid Staff Size
45
*2023 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Television, Internet, Radio, Corporate solicitation
Fundraising costs were 9% of related contributions. (Related contributions, which totaled $12,821,930, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on National Brain Tumor Society's audited financial statements for the year ended December 31, 2023.
Source of Funds
Interest, dividends and other | $373,625 |
Recovery of grant expense | $153,810 |
Gain on investments, net | $5,411 |
Fundraising and special events | $7,639,318 |
Grants and contributions | $4,546,587 |
Bequests | $575,529 |
In-kind contributions | $60,496 |
Total Income | $13,354,776 |
Programs: 84% Fundraising: 9% Administrative: 6%
Total Income | $13,354,776 |
Total expenses: | $12,250,254 |
Program expenses | $10,320,599 |
Fundraising expenses | $1,133,653 |
Administrative expenses | $796,002 |
Other expenses | $0 |
Income in Excess of Expenses | $1,104,522 |
Beginning Net Assets | $14,182,308 |
Other Changes In Net Assets | $0 |
Ending Net Assets | $15,286,830 |
Total Liabilities | $675,141 |
Total Assets | $15,961,971 |
Note: According to the organization’s 2023 audited financial statements, NBTS received in-kind gifts totaling $60,496 in the form of various raffle gifts and donated food items.
An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.
This report is not to be used for fundraising or promotional purposes.